MMV and SCYNEXIS offer 400 active compounds for neglected disease drug research at no cost

December 19, 2011

In a bid to catalyse malaria and neglected disease drug discovery, MMV and SCYNEXIS, Inc. have assembled a Malaria Box of 400 carefully selected commercially available compounds with antimalarial activity and will provide it to researchers at no cost.

All 400 compounds in the Malaria Box have confirmed activity against the blood-stage of P. falciparum - the most deadly of the malaria parasites - and were selected by experienced medicinal chemists from an extensive screening of around four million compounds from the chemical libraries of St. Jude Children's Research Hospital, Novartis and GlaxoSmithKline. The Malaria Box includes 200 drug-like compounds as starting points for oral drug discovery as well as 200 probe-like compounds representing the broadest cross-section of chemical diversity for use as biological tools.

"The discovery of novel molecules to feed the pipeline of antimalarial drugs remains a constant challenge," said Tim Wells, CSO of Medicines for Malaria Venture, "and all the more pressing in light of emerging resistance to current therapies. One of the rate-limiting factors for drug discovery is access to the actual active compounds with which to conduct research. With the Malaria Box concept, together with our partner SCYNEXIS, we hope to overcome this hurdle by carefully selecting and making available the most promising molecules to propel malaria drug discovery to the next level."

The scope of the Malaria Box goes beyond the malaria field as the compounds could also be used in research for drugs for other parasitic or neglected diseases. Making the compounds available to the entire neglected-disease community could lead to a better understanding of the similarities and differences between these diseases.

"SCYNEXIS is pleased to participate with MMV in the Malaria Box project as part of our on-going commitment to address the tremendous challenges presented by neglected diseases," said Yves Ribeill, President & CEO of SCYNEXIS, Inc. "SCYNEXIS stands ready to direct its proprietary technologies including its Integrated Parasitology Screening Platform and its HEOS® Collaborative Discovery Information Software Platform along with its highly experienced drug discovery teams to find innovative cures for these diseases."

The Malaria Box can be requested free-of-charge from MMV's website. All that is asked in return is that any data gleaned from research on the Box is published, shared and placed into the public domain to continue the virtuous cycle of research.
-end-


Medicines for Malaria Venture

Related Molecules Articles from Brightsurf:

Finally, a way to see molecules 'wobble'
Researchers at the University of Rochester and the Fresnel Institute in France have found a way to visualize those molecules in even greater detail, showing their position and orientation in 3D, and even how they wobble and oscillate.

Water molecules are gold for nanocatalysis
Nanocatalysts made of gold nanoparticles dispersed on metal oxides are very promising for the industrial, selective oxidation of compounds, including alcohols, into valuable chemicals.

Water molecules dance in three
An international team of scientists has been able to shed new light on the properties of water at the molecular level.

How molecules self-assemble into superstructures
Most technical functional units are built bit by bit according to a well-designed construction plan.

Breaking down stubborn molecules
Seawater is more than just saltwater. The ocean is a veritable soup of chemicals.

Shaping the rings of molecules
Canadian chemists discover a natural process to control the shape of 'macrocycles,' molecules of large rings of atoms, for use in pharmaceuticals and electronics.

The mysterious movement of water molecules
Water is all around us and essential for life. Nevertheless, research into its behaviour at the atomic level -- above all how it interacts with surfaces -- is thin on the ground.

Spectroscopy: A fine sense for molecules
Scientists at the Laboratory for Attosecond Physics have developed a unique laser technology for the analysis of the molecular composition of biological samples.

Looking at the good vibes of molecules
Label-free dynamic detection of biomolecules is a major challenge in live-cell microscopy.

Colliding molecules and antiparticles
A study by Marcos Barp and Felipe Arretche from Brazil published in EPJ D shows a model of the interaction between positrons and simple molecules that is in good agreement with experimental results.

Read More: Molecules News and Molecules Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.